Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Declines By 26.6%

Coloplast A/S (OTCMKTS:CLPBY) was the target of a significant drop in short interest in November. As of November 30th, there was short interest totalling 60,200 shares, a drop of 26.6% from the November 15th total of 82,000 shares. Based on an average daily volume of 182,400 shares, the short-interest ratio is currently 0.3 days.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CLPBY shares. Hsbc Global Res upgraded Coloplast A/S from a “moderate sell” rating to a “hold” rating in a report on Monday, November 18th. UBS Group raised shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research note on Wednesday.

Coloplast A/S Trading Up 1.7 %

Shares of CLPBY traded up $0.19 during trading hours on Friday, hitting $11.68. The company had a trading volume of 433,995 shares, compared to its average volume of 129,173. Coloplast A/S has a 52-week low of $11.08 and a 52-week high of $14.34. The company has a quick ratio of 0.56, a current ratio of 1.02 and a debt-to-equity ratio of 0.92. The stock’s 50 day moving average price is $12.71 and its 200 day moving average price is $12.85.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. The business had revenue of $1.02 billion for the quarter. Coloplast A/S had a return on equity of 30.19% and a net margin of 18.69%. On average, research analysts predict that Coloplast A/S will post 0.37 earnings per share for the current year.

Coloplast A/S Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, December 20th. Shareholders of record on Monday, December 9th will be issued a $0.2435 dividend. The ex-dividend date of this dividend is Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s dividend payout ratio (DPR) is 96.97%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.